Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Werewolf Therapeutics (HOWL) Times Interest Earned (2023 - 2025)

Werewolf Therapeutics (HOWL) has disclosed Times Interest Earned for 3 consecutive years, with -$11.73 as the latest value for Q3 2025.

  • On a quarterly basis, Times Interest Earned rose 14.81% to -$11.73 in Q3 2025 year-over-year; TTM through Sep 2025 was -$13.85, a 8.01% increase, with the full-year FY2024 number at -$15.81, down 22.5% from a year prior.
  • Times Interest Earned was -$11.73 for Q3 2025 at Werewolf Therapeutics, up from -$13.48 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of -$6.35 in Q2 2023 to a low of -$71.06 in Q1 2023.
  • A 3-year average of -$18.41 and a median of -$13.77 in 2024 define the central range for Times Interest Earned.
  • Biggest YoY gain for Times Interest Earned was 75.92% in 2024; the steepest drop was 161.34% in 2024.
  • Werewolf Therapeutics' Times Interest Earned stood at -$12.83 in 2023, then dropped by 25.14% to -$16.06 in 2024, then grew by 26.98% to -$11.73 in 2025.
  • Per Business Quant, the three most recent readings for HOWL's Times Interest Earned are -$11.73 (Q3 2025), -$13.48 (Q2 2025), and -$14.24 (Q1 2025).